We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » 483 Roundup: FDA Raps Four Firms for Quality Lapses
483 Roundup: FDA Raps Four Firms for Quality Lapses
FDA investigators observed various quality deficiencies during inspections of drug manufacturing facilities in North Carolina, Kansas, Florida and California.